Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 July - 15 July 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- (individual housing of mice instead of group housing due to aggression in caged mice)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 22 July 2010
- Deviations:
- yes
- Remarks:
- (individual housing of mice instead of group housing due to aggression in caged mice)
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: The test item was stored in a cold dark place (prefabricated refrigerator, 8.6 to 11.4°C), protected from light, in a well-closed container.
- Stability of test article: stable for one year, at room temperature
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Remarks:
- CBA/J [SPF]
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Japan, Inc., Japan
- Age at study initiation: 9 weeks
- Weight at study initiation: 20.5 - 24.6 g
- Housing: individual in wire mesh metal cages with an automatic water flushing breeding rack (Toyoriko), the feeders were exchanged once a week
- Diet: pellet diet CRF-1 (Oriental Yeast, lot No. 131108), ad libitum
- Water: ad libitum (analysis was performed)
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.9 - 23.1
- Humidity (%): 53.6 - 62.2
- Air changes (per hr): ≥ 12
- Photoperiod (hrs dark / hrs light): 12/ 12
- IN-LIFE DATES: From: 09 July To: 15 July 2014
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Remarks:
- (DMF)
- Concentration:
- 10, 25 and 50% (w/v) in DMF; prepared just before use
- No. of animals per dose:
- 4
- Details on study design:
- PRE-SCREEN TEST:
In the pre-screening test, three concentrations (10, 25 and 50% solution in DMF) were selected, and 25 μl each dose formulation were applied on the dorsal skin of both auricles of each animal, 2 mice for each concentration, once a day for 3 consecutive days. The general conditions including an observation of the application site were performed once each day (from 1 to 3 hours after the application to day 6). As a result, no animals showed any abnormalities. The body weights and ear thickness were measured before the initial application and on Day 6. None of the animals showed any changes deviating from the criteria of body weights (less than 5% weight change) and ear thickness (less than 25% increase in ear thickness). No rationale given for dose selection in the pre-screen test.
From the results mentioned above, 50% was selected as the high concentration for the main study, because it was expected not to induce any toxic signs in the general condition, 25% or more increase in the ear thickness, dermal erythema with score of 3 or more on the auricles, or more than 5% of body weight loss, and two lower concentrations of 25 and 10%.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: 3H-methylthymidine incorporation determined by ß-scintillation
- Criteria used to consider a positive response: A substance is regarded as a sensitizer in the LLNA, if the Stimulation Index (SI) is 3 or greater.
TREATMENT PREPARATION AND ADMINISTRATION: 25 µl of each dose formulation were applied to the dorsal skin of auricles of each animal once a day (using a MICROMAN (Model M100, Gilson) for 3 days. On day 6 20 μCi [methyl-3H] thymidine (3HTdR) (= 250 μL of 80 μCi/mL 3HTdR solution) was administered intravenously to each mouse via the tail vein with disposable syringes and 27G needles. 5 h after administration local lymph nodes were collected and minced and then the pooled lymph node cells (LNC) were treated with 5% TCA overnight (approximately 18 hours) before determination of the ammount of 3HTdR incorporation on day 7. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- No statistical analysis were performed.
Results and discussion
- Positive control results:
- The positive control substance (25% α-Hexylcinnamaldehyde (Lot # LAP0946, Wako Pure Chemical Industries, Ltd, Japan) in DMF) induced a positive reaction, determined by a DPM/animal of 5317.9 compared to 1094.5 DPM/animal in the control group, leading to a SI of 4.9. No abnormal clinical signs, erythema on the auricles or body weight changes on day 6 were observed. The weights of lymph nodes were however much larger than those in the vehicle control group (9.9 +/- 0.8 vs 5.2 +/- 0.8 in HCA treated animals and control group, respectively) and the ear thickness of animals treated with the test substance was larger than that in the vehicle control group (day 3: 0.15 +/- 0.009 mm vs 0.13 +/- 0.005; day 6: 0.18 +/- 0.009 mm vs 0.13 +/- 0.005, respectively).
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- 10 % test group
- Key result
- Parameter:
- SI
- Value:
- 4
- Test group / Remarks:
- 25% test group
- Key result
- Parameter:
- SI
- Value:
- 3.1
- Test group / Remarks:
- 50% test group
- Parameter:
- SI
- Value:
- 4.9
- Test group / Remarks:
- positive control group
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
Lymph node weight was not altered compared to that of the vehicle control group (5.2 +/- 0.8, 5.4 +/- 0.4 , 6.4 ± 0.8, 6.1 ± 0.7 for control, 10, 25 and 50% test substance, respectively). Topical application of the test substance led to an increase in the mean DPM values of pooled lymph nodes. The following values were obtained: 1094.5, 1831.8, 3432.9 and 3402.8 DPM/animal in control, 10, 25 and 50% test groups.
DETAILS ON STIMULATION INDEX CALCULATION
The SI was derived by dividing the mean DPM/mouse within each test substance group and positive control group by the mean DPM/mouse for the vehicle control group. The following values were obtained: 1.7, 4.0, 3.1 and 4.9 for 10, 25 and 50% test substance and the positive control substance HCA, respectively.
EC3 CALCULATION
The EC3 value was estimated via quadratic regression. The allergenic potency class of the test substance was assigned depending on the EC3 value using the GHS categorization scheme.
The EC3 value of the test substance was calculated to be 16.8% via quadratic regression.
CLINICAL OBSERVATIONS and BODY WEIGHTS
No abnormal clinical signs, erythema on the auricles or body weight increases or decreases on day 6 were observed. Neither individual ear thickness was altered compared to that of the vehicle control croup.
Any other information on results incl. tables
Table 1: Stimulation index in mice after application of the vehicle (DMF), test substance (10, 25, 50% in DMF) or positive control substance (25% HCA in DMF)
Compound |
Concentration [%] |
Number of animal |
DPM/ animal |
Stimulation index |
Judgement |
GHS classification |
DMF |
100 |
4 |
1094.5 |
- |
- |
- |
Test substance |
10 |
4 |
1831.8 |
1.7 |
Negative |
1B |
25 |
4 |
4342.9 |
4.0 |
Positive |
||
50 |
4 |
3402.8 |
3.1 |
Positive |
||
HCA |
25 |
4 |
5317.9 |
4.9 |
Positive |
- |
- = Not applicable
Stimulation index (SI) =DPM/animal of group 2 - 5)/(DPM/animal of group 1
Judgement: The cases showing three or greater SI values were defined as positive.
DMF = N,N -Dimethylformamide
HCA = α-Hexylcinnamaldehyde
The classification of skin sensitization was conformed to the "Globally Harmonized System of Classification and Labelling of Chemicals (GHS)" (5th revised edition, United Nations, 2013).
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- CLP: Skin Sens 1B, H317
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Die ECHA bietet zahlreiches Online-Material in Ihrer Sprache an, ein Teil dieser Seite liegt jedoch nur auf Englisch vor. Mehr über die Praxis der Mehrsprachigkeit bei der ECHA.
Willkommen auf der Website der ECHA! Unsere Website wird von Internet Explorer 7 (und älteren Versionen) nicht uneingeschränkt unterstützt. Bitte verwenden Sie Internet Explorer in einer neueren Version.
Damit Sie die Website optimal nutzen können, verwenden wir Cookies.
Weitere Informationen über unsere Verwendung von Cookies.